Bank of New York Mellon’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $37.3M | Sell |
|
|||||
|
2025
Q2 | $55.6M | Sell |
|
|||||
|
2025
Q1 | $58.3M | Buy |
|
|||||
|
2024
Q4 | $68.1M | Sell |
|
|||||
|
2024
Q3 | $96.9M | Buy |
|
|||||
|
2024
Q2 | $115M | Buy |
|
|||||
|
2024
Q1 | $102M | Sell |
|
|||||
|
2023
Q4 | $83M | Sell |
|
|||||
|
2023
Q3 | $78.5M | Sell |
|
|||||
|
2023
Q2 | $70.9M | Buy |
|
|||||
|
2023
Q1 | $67.8M | Sell |
|
|||||
|
2022
Q4 | $61M | Sell |
|
|||||
|
2022
Q3 | $48.3M | Sell |
|
|||||
|
2022
Q2 | $57.1M | Buy |
|
|||||
|
2022
Q1 | $54.4M | Buy |
|
|||||
|
2021
Q4 | $49.5M | Buy |
|
|||||
|
2021
Q3 | $39.6M | Buy |
|
|||||
|
2021
Q2 | $30.6M | Buy |
|
|||||
|
2021
Q1 | $22.8M | Buy |
|
|||||
|
2020
Q4 | $20.6M | Buy |
|
|||||
|
2020
Q3 | $18.3M | Buy |
|
|||||
|
2020
Q2 | $17.1M | Sell |
|
|||||
|
2020
Q1 | $63.6M | Buy |
|
|||||
|
2019
Q4 | $60.8M | Sell |
|
|||||
|
2019
Q3 | $55.1M | Buy |
|
|||||
|
2019
Q2 | $53.8M | Sell |
|
|||||
|
2019
Q1 | $55.7M | Sell |
|
|||||
|
2018
Q4 | $49.4M | Sell |
|
|||||
|
2018
Q3 | $53.3M | Sell |
|
|||||
|
2018
Q2 | $54M | Sell |
|
|||||
|
2018
Q1 | $61.4M | Sell |
|
|||||
|
2017
Q4 | $70.1M | Sell |
|
|||||
|
2017
Q3 | $64.4M | Sell |
|
|||||
|
2017
Q2 | $60.1M | Sell |
|
|||||
|
2017
Q1 | $52M | Sell |
|
|||||
|
2016
Q4 | $58M | Sell |
|
|||||
|
2016
Q3 | $75.2M | Sell |
|
|||||
|
2016
Q2 | $103M | Sell |
|
|||||
|
2016
Q1 | $110M | Sell |
|
|||||
|
2015
Q4 | $136M | Sell |
|
|||||
|
2015
Q3 | $146M | Sell |
|
|||||
|
2015
Q2 | $179M | Sell |
|
|||||
|
2015
Q1 | $196M | Sell |
|
|||||
|
2014
Q4 | $156M | Sell |
|
|||||
|
2014
Q3 | $192M | Sell |
|
|||||
|
2014
Q2 | $187M | Sell |
|
|||||
|
2014
Q1 | $188M | Sell |
|
|||||
|
2013
Q4 | $153M | Sell |
|
|||||
|
2013
Q3 | $143M | Sell |
|
|||||
|
2013
Q2 | $147M | Buy |
|